← Eichor
Study identifier: NCT06451146 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Lower Silesian Orbital Atherectomy Registry (LOAR)

Condition: Safety Issues · Efficacy, Self  ·  Sponsor: Regional Cardiology Center, The Copper Health Centre (MCZ),

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The Lower Silesian Orbital Atherectomy Registry (LOAR), is an observational registry collecting all consecutive cases of percutaneous coronary intervention (PCI) performed with the support of the Orbital Atherectomy Device due to the presence of calcified lesion in coronary arteries. Data will be collected in two cooperating cardiac centers (Department of Cardiology, The Copper Health Center, Lubin, Poland, and Department of Cardiology, Provincial Specialized Hospital in Legnica, Poland).

This description comes directly from the study's public registry record.

Talk to the study team

Piotr Rola, MD; PhD  ·  +48767211446  ·  piotr.rola@gmail.com

Adrian Włodarczak, Assoc Prof.  ·  +48768460300  ·  wlodarczak.adrian@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Department of Cardiology, Provincial Specialized Hospital in LegnicaLegnica, Lower Silesian Voivodeship, PolandRecruiting
Department of Cardiology, The Copper Health Centre (MCZ)Lubin, Lower Silesian Voivodeship, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06451146